PMID: 9519088Mar 31, 1998Paper

Costs of schizophrenia

The British Journal of Psychiatry : the Journal of Mental Science
M Knapp

Abstract

Schizophrenia is a common and burdensome illness, with implications not only for the health service but for a host of other care agencies--public and private--as well as for patients, families and the wider society. The paper reviews available UK evidence on the cost of schizophrenia (broadly defined) and on the cost-effectiveness of treatment options and alternative care arrangements. New evidence potentially alters our view of the costs of this illness. Aggregating the identifiable direct and indirect costs of schizophrenia for England suggests an annual cost of 2.6 billion pounds, but even this sum omits some indirect impacts which cannot currently be costed. Just over half the identified total is accounted for by the direct costs falling to the NHS, local authorities, charities and the criminal justice system. In helping to tackle this cost burden, there is now a body of evidence on cost-effective community care arrangements, antipsychotic drugs and psychological interventions. Although the costs of schizophrenia are considerable, there are treatments and care arrangements which can reduce this aggregate burden while maintaining or improving effectiveness.

References

Sep 1, 1975·The American Journal of Psychiatry·J G Gunderson, L R Mosher
Jun 1, 1978·The American Journal of Psychiatry·J EndicottM Gibbon
Jan 1, 1992·Social Psychiatry and Psychiatric Epidemiology·R G McCreadie
Jul 1, 1992·Schizophrenia Research·D W Black, R Fisher
Mar 1, 1991·Archives of General Psychiatry·B J CaroneJ F Westermeyer
Oct 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·N TarrierC Barrowclough
Jan 1, 1991·Schizophrenia Bulletin·T G McGuire
Oct 26, 1991·BMJ : British Medical Journal·D MelzerS Wood
Mar 1, 1991·Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing·M L SelbyD Quade
Jan 1, 1989·Schizophrenia Bulletin·P Allebeck
Feb 1, 1989·Geriatric Nursing and Home Care·E Farmer
Dec 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·C HydeB Faragher
Jun 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·J LeffD Sturgeon
Jan 1, 1985·Epidemiologic Reviews·W W Eaton
Jun 1, 1985·Archives of General Psychiatry·G AndrewsD Silove
Jul 1, 1974·Archives of General Psychiatry·T Van Putten
Apr 1, 1980·Archives of General Psychiatry·B A WeisbrodL I Stein
Jan 1, 1995·Schizophrenia Bulletin·P J Weiden, M Olfson
Sep 1, 1995·Acta Psychiatrica Scandinavica·D Jonsson, J Wålinder
Jan 1, 1995·The American Journal of Psychiatry·S M Essock
Jun 1, 1995·The American Journal of Psychiatry·W T CarpenterC A Tamminga
Jan 1, 1995·Schizophrenia Bulletin·S M Evers, A J Ament
Jan 1, 1995·Social Psychiatry and Psychiatric Epidemiology·R Jenkins, H Meltzer
Jan 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·K SmithG Lewis
Aug 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·I M MarksR E Lawrence
Aug 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·M KnappM Muijen
Aug 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·B AudiniV Watts
Aug 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·P McCroneM Knapp
Aug 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·W XiongA Kleinman
Nov 1, 1993·The American Journal of Psychiatry·H Y MeltzerB Snitz
Sep 25, 1993·BMJ : British Medical Journal·T Hale
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·M HassanM Lindgren
Jul 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·T BurnsC Mathers
Jul 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·T BurnsM Dickson
Jan 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·L M Davies, M F Drummond
Feb 10, 1996·BMJ : British Medical Journal·R KempA David

❮ Previous
Next ❯

Citations

Apr 23, 2002·The Journal of Mental Health Policy and Economics·Simon M. Gilbody, Mark Petticrew
Jul 26, 2002·Pharmacoepidemiology and Drug Safety·Darren M AshcroftStephen R Chapman
Sep 10, 2005·Social Psychiatry and Psychiatric Epidemiology·Paul E BebbingtonUNKNOWN EuroSC Research Group
Mar 28, 2006·Social Psychiatry and Psychiatric Epidemiology·Alberto ParabiaghiMorven Leese
Nov 13, 2009·European Archives of Psychiatry and Clinical Neuroscience·T WobrockW Gaebel
Aug 10, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Stephen M BeardEckart Rüther
Jul 20, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Juan Oliva-MorenoBeatriz Duque-González
Jun 1, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Wulf RösslerAnita Riecher-Rössler
May 4, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Simon SurguladzeMichael J Travis
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Albert Hung Choy Wong, Hubert H M Van Tol
Dec 2, 2000·Schizophrenia Research·V Kumari, T Sharma
Aug 22, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·J LynchJ S Hellewell
Jan 5, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·M Z DernovsekR Tavcar
Sep 17, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·L Hosák, R Bahbouh
Jan 1, 1998·European Psychiatry : the Journal of the Association of European Psychiatrists·M Knapp
Jul 28, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M LandénK Blennow
Feb 19, 1999·Epidemiologia e psichiatria sociale·M Percudani, M Knapp
May 2, 2000·The Australian and New Zealand Journal of Psychiatry·A JablenskyC Harvey
Sep 11, 2007·The Australian and New Zealand Journal of Psychiatry·Paul B FitzgeraldJayashri Kulkarni
Jul 19, 2001·International Clinical Psychopharmacology·S KasperUNKNOWN RODOS Investigator Group
May 1, 2002·International Clinical Psychopharmacology·M KnappA David
May 16, 2008·Journal of Clinical Psychopharmacology·Susan Shur-Fen GauChurn-Shiouh Gau
Nov 18, 2008·Journal of Clinical Psychopharmacology·Jelle VehofHuibert Burger
May 18, 2004·The Australian and New Zealand Journal of Psychiatry·N Srinivasan TirupatiPadmavati Raman
Apr 6, 2006·Psychiatry and Clinical Neurosciences·Miharu NakanishiTeruhiko Higuchi
May 10, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P Andlin-Sobocki, W Rössler
Sep 1, 2000·BMJ : British Medical Journal·S Frangou, P Byrne
Aug 21, 2007·BMC Health Services Research·Dong-Sheng TzengFor-Wey Lung
Jun 21, 2013·Neuropsychiatric Disease and Treatment·Mitsuhiro SadoKimio Yoshimura
Nov 7, 2000·PharmacoEconomics·E Lindström, K Bingefors
Oct 1, 2005·Indian Journal of Psychiatry·Sandeep GroverParamanand Kulhara
Mar 25, 2009·Community Mental Health Journal·A D StantD Wiersma
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Vaughan J CarrScott Holmes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here